News

The company has received the US Food and Drug Administration approval for Cuvposa in July 2010 on the basis of a Phase III study of 38 subjects which

Banner Pharmacaps is a specialty pharmaceutical company engaged in research, development, and manufacturing of gelatin-based dosage forms. Impax president and CEO Larry Hsu said in less than a

The new patent entitled, ‘Solid Ganaxolone formulations and methods for the making and use thereof,’ describes a novel class of small molecules to improve stability and bioavailability of

The first trail results showed that VB-111 was safe and specific and may offer additive effect to chemotherapy. In the trial, the researchers investigated the safety and efficacy

SIRO Clinpharm, a global clinical research organizations (CRO), offers full scope services, conducting clinical trials in the pharmaceutical, biotechnology and medical devices sectors. The company has offices in

The study of AVL-292-001 was a double-blind, placebo-controlled, single ascending dose study in healthy volunteers and in this study AVL-292 demonstrated favorable safety, tolerability and pharmacokinetics. In addition,

Pollinex Quattro is a four injection therapeutic vaccine for the treatment of allergic conditions which offers same season relief in as little as three weeks after treatment. Following

OctoPlus is a European provider of advanced drug formulation and clinical scale manufacturing services to the pharmaceutical and biotechnology industries. As per the agreement OctoPlus is expected to

SYN115 is an orally bioavailable, potent and selective adenosine A2a receptor antagonist, which enters the brain and modulates regions associated with motor and non-motor function. Biotie obtained development